If I am looking at the table in announcement of 5 June, at end of trial to enrolment in Extension trial compassion use ALSFRS-R was.
1. 42 at end of trial after 4.5 months rating 39
2. 40 at end of trial after 1.5 months rating 42 improvement
3. 39 after 4.5 months 32
4. 37 after 2.5 months 34
5. 36 after 1.5 months 35
6. 35 after 2.5 months 31
7. 30 after 2.5 months 30
8. 22 after 2.5 months 22
9. 15 after 2.5 months 6
10. 12 after 2.5 months 12
Ann: OLE Study update reveals impressive Survival Data, page-242
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |